In a firm reaffirmation of the stringent provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, the XXXIII Addl. City Civil & Sessions Judge & Special Judge (NDPS), Smt. B.S. Jayashree, Bengaluru, rejected the bail petition of Anand Chandran, the accused in a significant drug seizure case. The order, passed on September 2, 2023, highlighted the recovery of a commercial quantity of psychotropic substances and other narcotics, negating the petitioner’s claim for relief under Section 439 of the Cr.P.C.
The petitioner, Anand Chandran, identified as Accused No. 1, was arrested in connection with Cr. No. 17/2023 registered at Suddaguntepalya Police Station. The charges against him include offences punishable under Sections 8(c), 22(c), 20(ii)(a), and 29 of the NDPS Act, relating to the possession and trade of narcotic drugs.
The Seizure and Prosecution Case
The criminal law was put into motion by the PI, CCB (W & N), following a credible information received on January 23, 2023, regarding drug sales at a house in Venkateshwara layout, Suddaguntepalya. A raid was conducted, resulting in the apprehension of the petitioner and two other accused, as well as the seizure of a significant cache of contraband.
The key items seized, as detailed in the prosecution papers, included:
- 102.21 grams of MDMA crystal
- 43.43 grams of MDMA ecstasy pills
- 267.74 grams of Ganja (Cannabis)
- 83.37 grams of Hashish Oil (Hash oil)
- A weighing machine
The prosecution, while opposing the bail petition, contended that the accused was a habitual drug dealer and that the seized quantities constituted a commercial quantity, making the offence punishable with rigorous imprisonment of up to 20 years and a fine. The prosecution strongly argued that if released on bail, the petitioner might continue his illegal trade, abscond, or tamper with the evidence.
Petitioner’s Grounds and the FSL Report Contention
The petitioner, through his counsel Sri. BM., Adv., sought bail primarily on the grounds of false implication and non-compliance with the procedures under the NDPS Act and Cr.P.C. Crucially, the petitioner raised specific points regarding the contents and quantity of the seized material based on the Forensic Science Laboratory (FSL) report.
The defence argued the following points:
- MDMA Crystal: The sample from the 102.21 grams of MDMA crystal (Article No. 1) tested positive for N, N-Dimethylpentylone but negative for Methamphetamine/MDMA. The petitioner contended that N, N-Dimethylpentylone is not mentioned in Schedule-1 of the NDPS Act, thereby not attracting the severe provisions of the Act for this substance.
- MDMA Pills Quantity: Regarding the 43.43 grams of MDMA ecstasy pills (Article No. 2), which tested positive for Amphetamine, MDMA, and Caffeine, the petitioner argued that the seized quantity of Amphetamine (43.43 grams) was below the commercial quantity threshold of 50 grams, as per the Central Government notification.
- Other Substances: The other two seized articles (Ganja and Hashish oil) were categorized as small quantities, which, according to the defence, collectively meant that the rigors of Section 37 of the NDPS Act—the stringent ‘twin conditions’ for bail—should not apply.
Court’s Rejection: Focusing on Commercial Quantity of MDMA
The court meticulously analyzed the FSL report and the relevant notification (S.O. 1055(E) dated 19.10.2001). While acknowledging the FSL finding that the 102.21 grams of MDMA crystal did not contain MDMA, the court focused its attention on the second substance: the 43.43 grams of MDMA ecstasy pills.
The court noted that the FSL report confirmed that the 43.43 grams of ecstasy pills tested positive for MDMA (Methylenedioxymethamphetamine), Amphetamine, and Caffeine. The court then confirmed the statutory thresholds: for MDMA, 0.5 grams is a small quantity and 10 grams is a commercial quantity.
The final ruling on the quantity was conclusive: the 43.43 grams of MDMA ecstasy pills seized from the petitioner was substantially above the 10-gram commercial quantity threshold for MDMA. This crucial finding invoked the mandatory limitations on bail imposed by Section 37 of the NDPS Act.
Strict Application of NDPS Section 37
The Special Judge emphasized that the NDPS Act mandates deterrent punishment for illicit drug trafficking and that the ‘twin conditions’ under Section 37 must be satisfied before bail can be granted for commercial quantity offences:
- The court must have reasonable grounds for believing that the accused is not guilty of the offence.
- The court must be satisfied that the accused is not likely to commit any offence while on bail.
Citing the Hon’ble Apex Court judgments in State of Kerala Vs. Rajesh (2020) and State of MP Vs. Kajad (2001), the court reiterated that a “liberal approach” in granting bail under the NDPS Act is “uncalled for” and that “Negation of bail is the rule and its grant an exception.” The term “reasonable grounds” requires “something more than prima facie grounds,” demanding “substantial probable causes” to believe the accused is innocent.
Finding “primafacie material” against the petitioner regarding the possession of a commercial quantity of MDMA, the court concluded that the petitioner had failed to satisfy the mandatory twin conditions of Section 37. The total recovery, which included MDMA (a commercial quantity), Ganja, and Hashish oil, painted a clear picture of drug trade involvement.
The petition filed by Anand Chandran under Section 439 of Cr.P.C. was thus rejected, confirming the judiciary’s commitment to tackling drug-related crimes with the full force of the NDPS Act.